Clinical Trials Logo

Lymphedema clinical trials

View clinical trials related to Lymphedema.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06278298 Active, not recruiting - Clinical trials for Lymphedema of Upper Limb

Different Level of ECSWT in Post Mastectomy Lymphedema

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

to investigate the effectiveness of different dosages of ECSW in the treatment of post mastectomy lymphedema volume and quality of life (Qol)

NCT ID: NCT05742945 Active, not recruiting - Clinical trials for Breast Cancer Lymphedema

Can ILR Reduce the Risk of Arm Lymphedema?

Start date: February 14, 2023
Phase: N/A
Study type: Interventional

Breast cancer-related lymphedema (BCRL) is a debilitating, usually lifelong burden for breast cancer survivors. For the breast cancer patients receiving axillary lymph node dissection (ALND), the likelihood of BCRL is about 20%. Lymphatico-venous anastomosis (LVA) has been accepted as a method of treating extremity lymphedema. A few studies have mentioned the prophylactic effect of LVA on BCRL. However, there is still lack of a large-scale randomized controlled trial to corroborate its efficacy. Therefore, the goal of this study is to conduct a prospective randomized controlled trial to evaluate if immediate lymphatic reconstruction (ILR) with LVA could have a clinically significant effect on the reduction of BCRL occurrence.

NCT ID: NCT05613946 Active, not recruiting - Lymphedema Arm Clinical Trials

Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema

CASTLE
Start date: December 15, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this research is to determine the preferred microbubble agent (Lumason®, Optison®, and Definity®) for lymphatic channel visualization by ultrasound. This research will also evaluate the utility of preoperative high-frequency B-mode ultrasound with contrast-enhanced ultrasound for presurgical planning, and ultrasound shear wave elastography for assessing treatment response at 6-month follow up.

NCT ID: NCT05441943 Active, not recruiting - Breast Cancer Clinical Trials

Lymphaticovenous Anastomosis as Treatment for Lymphedema

Start date: May 11, 2022
Phase: N/A
Study type: Interventional

The primary aim of this study is to investigate and test whether the use of combined indocyanine green (ICG) lymphography and ultra high frequency ultrasonography can correctly identify lymphatic vessels and venoles in close proximity to each other, for identification prior to lymphovenous anastomosis (LVA) surgery.

NCT ID: NCT05056207 Active, not recruiting - Lymphedema Clinical Trials

PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema

Start date: November 17, 2017
Phase: N/A
Study type: Interventional

This research study is to learn about breast cancer patients' opinions about screening for lymphedema (a side effect of breast cancer treatment in which the arm can become heavy, painful, and/or swollen) and their satisfaction with the lymphedema screening program.

NCT ID: NCT05022823 Active, not recruiting - Clinical trials for Breast Cancer Related Lymphedema

Exercise and Compression for Lymphedema

DREAM
Start date: June 29, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the benefit of combining resistance exercise with use of a compression sleeve on arm lymphedema. In the study, participants will be taught a resistance exercise that follows the decongestive exercise sequence. This program is called "decongestive progressive resistance exercise" (DPRE). To evaluate the benefit from use of a compression garment on the arm. Some participants will wear their usual compression sleeve during exercise and others will use an adjustable compression wrap. The investigators hope to see if this type of combined program is helpful for women with lymphedema. The investigators also want to see if there are benefits from the addition of use of an adjustable compression wrap during exercise over use of a regularly prescribed compression sleeve.

NCT ID: NCT04987424 Active, not recruiting - Clinical trials for Unilateral Breast Cancer

Prevalence of Lymphedema in Valle Del Cauca, Colombia.

Start date: January 18, 2018
Phase:
Study type: Observational

This is an epidemiological cross-sectional study aiming to determine the prevalence of lymphedema and the incidence of risk factors in patients diagnosed with unilateral breast cancer in a cohort from 2008 to 2020 in a specialised oncology centre in Valle del Cauca, Colombia.

NCT ID: NCT04974268 Active, not recruiting - Lymphedema Clinical Trials

Reduction of Lymphedema Secondary to Breast Cancer

EJERDIETLIF
Start date: May 17, 2021
Phase: N/A
Study type: Interventional

This study evaluates the reduction of lymphedema and its complications in obese women treated with a muscle training and weight loss program as well as the improvement body composition, muscle strength, quality of life and neurocognitive function, compared to a conventional treatment control group.

NCT ID: NCT04872738 Active, not recruiting - Covid19 Clinical Trials

Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment

LymphVAX
Start date: May 7, 2021
Phase:
Study type: Observational

This study aims to elicit patient experiences, choices, and side effects associated with the COVID-19 vaccine after breast cancer surgery. Lymph node swelling is a known and common side effect of both the Moderna and Pfizer COVID-19 vaccines. This is the body's normal reaction to the vaccine. It is worrisome that lymph node swelling after the vaccine mimics that found in breast cancer which has spread to the lymph nodes. This side effect will cause worry and anxiety amongst patients as a result. For patients who have had lymph node removal (axillary lymph node dissection or sentinel lymph node biopsy) and are at risk of lymphedema, the investigators are concerned that the lymph node swelling may tax the lymphatic system and incite lymphedema in those at risk or worsen it in those with BCRL. Fear of lymphedema is high in this population and the investigators need to better understand what risk, if any, lymph node swelling after the COVID-19 vaccine imparts to BCRL risk.

NCT ID: NCT04797390 Active, not recruiting - Lymphedema Clinical Trials

A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Start date: September 23, 2021
Phase: N/A
Study type: Interventional

To compare the effectiveness of an APCD to Usual Care in the management of lymphedema and fibrosis (LEF) in head and neck cancer (HNC) survivors.